Evidence map›Paper›PMID 20543588›Full record

ReviewCurrent opinion in HIV and AIDS2010

Th17 cytokines in mucosal immunity and inflammation.

Lokesh Guglani, Shabaana A Khader

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in HIV and AIDS, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 2 syntheses or guidelines pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Effect of the intestinal microbiota on TSeminars in immunopathology · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. bioRxiv : the preprint server for biology · 2025
    Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lokesh GuglaniDivision of Pulmonary Medicine, Allergy and Immunology, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA 15224, USA.
Shabaana A Khader
Children's Hospital of Pittsburgh · US

Funding

Novel IL-17 producing memory cells are key to vaccine-based immunity in the lungR00AI075106 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KHADER, SHABAANA A. · 2008 to 2009
$486k
Impact of mucosal immunization on generation of protective lung-resident IL-17 prR21AI083541 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KHADER, SHABAANA A. · 2009 to 2010
$417k
Novel IL-17 producing memory cells are key to vaccine-based immunity in the lungK99AI075106 · NIAID · TRUDEAU INSTITUTE, INC. · PI KHADER, SHABAANA A. · 2007 to 2007
$90k
NIAID NIH HHS AI 075106NIAID NIH HHS AI 083541NIAID NIH HHS K99 AI075106NIAID NIH HHS R00 AI075106NIAID NIH HHS R21 AI083541
6 · The paper itself

Abstract

purpose of reviewCompelling evidence suggests that the Th17 lineage and other IL-17-producing cells play critical roles in host defense against pathogens at mucosal sites. However, IL-17 can also contribute to inflammatory responses at mucosal sites. In this review, we will discuss the recent progress in our understanding of the role of Th17 and other IL-17-producing cells in defining the fine balance between immunity and inflammation at different mucosal sites. RECENT FNDINGS: Recent findings have highlighted that Th17 cytokines are important for the induction of innate and adaptive host responses and contribute to host defense against pathogens at mucosal sites. More recent developments have probed how the Th17 responses are generated in vivo in response to infections and their requirement in maintaining barrier function at mucosal sites. Most importantly, it is becoming apparent that there is a fine balance between protective and pathological manifestation of Th17 responses at mucosal sites that defines immunity or inflammation. SUMMARY: In this review, we have summarized the recent advances in our understanding of Th17 cytokines and how they contribute to immunity versus inflammation at mucosal sites.

Indexed as

Immunity, MucosalAnimalsCytokinesHumansInflammationT-Lymphocytes, Helper-InducerCytokines

Identifiers

PMID20543588
PMCPMC2892849
OpenAlexW2036088920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.